Aether Industries
- Market Cap
- ₹21,506 Cr
- P/E
- 86.28
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 11.90%
- Debt to Equity
- 0.26
- EPS (TTM)
- ₹18.78
- Book Value
- ₹195.44
- Market Cap
- ₹21,506 Cr
- P/E (TTM)
- 86.28
- P/B
- 8.29
- ROE
- 9.66%
- Dividend Yield
- 0.00%
- EBITDA
- ₹385 Cr
- 52W High
- ₹1,814.10
- 52W Low
- ₹800.45
- Day Range
- ₹1,617.00 – ₹1,701.00
- Volume
- 1,84,543
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| 1,620.00 | 61.46 | 1,64,897 | 14.71 | 1.41% | 23.90% | 31.00% | 16,142 | 2,718 | |
| 4,932.70 | 80.98 | 54,186 | 6.46 | 0.06% | 7.82% | 9.64% | 5,853 | 661 | |
| 10,077.00 | 56.75 | 51,687 | 11.58 | 0.08% | 19.80% | 21.00% | 4,066 | 910 | |
| 1,620.30 | 86.28 | 21,506 | 8.29 | 0.00% | 9.66% | 11.90% | 1,298 | 249 | |
| 1,531.20 | 19.66 | 20,885 | 3.23 | 0.48% | 9.82% | 11.40% | 9,749 | 1,063 | |
| 5,488.50 | 34.93 | 16,828 | 5.74 | 0.20% | 16.60% | 21.50% | 2,604 | 481 | |
| 449.50 | 27.49 | 16,299 | 2.60 | 0.22% | 7.17% | 6.86% | 10,579 | 593 | |
| Median 7 companies | 1,620.30 | 56.75 | 21,506 | 6.46 | 0.20% | 9.82% | 11.90% | 5,853 | 661 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 40
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 14
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 96
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 76
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 97
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 51
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Stock is trading at 8.29 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.91% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 3 | 7 | 9 |
| Oscillators | Bullish | 0 | 7 | 2 |
| Moving Averages | Strong Bullish | 3 | 0 | 7 |
Oscillators
Bullish
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 50.38
- Neutral
- MACD (12,26,9)
- 15.13
- Bullish
- SMA (50)
- 1,627.89
- Bearish
- SMA (200)
- 1,344.42
- Bullish
As of
Analyst Rating
4 of 7 analysts rate Buy, 1 Hold, 2 Sell.
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 3Y | +21.23% |
|---|---|
| 1Y | +37.93% |
| TTM | +30.19% |
Net profit
| 3Y | +18.99% |
|---|---|
| 1Y | +38.61% |
| TTM | +28.35% |
Operating cash flow
| 3Y | Turned positive |
|---|---|
| 1Y | +42.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 3Y | +2.81 pp |
|---|---|
| 1Y | +2.49 pp |
| TTM | −0.06 pp |
Revenue by year
| Mar 2022 | ₹590 Cr |
|---|---|
| Mar 2023 | ₹651 Cr |
| Mar 2024 | ₹598 Cr |
| Mar 2025 | ₹841 Cr |
| Mar 2026 | ₹1,160 Cr |
Net profit by year
| Mar 2022 | ₹109 Cr |
|---|---|
| Mar 2023 | ₹130 Cr |
| Mar 2024 | ₹82.00 Cr |
| Mar 2025 | ₹158 Cr |
| Mar 2026 | ₹219 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Aether Industries Ltd trades at ₹1,696.5 as of 2026-11-19 with a market cap of ₹22,517 crore. The stock commands a premium valuation at a P/E of 90.34x and P/B of 8.68x, supported by compounded sales growth of 21% over 3 years and TTM sales growth of 30%, but offset by a modest ROE of 8.94% and zero dividend payout.
- Strong TTM sales growth of 30% indicates accelerating revenue momentum and improving demand for its specialty chemicals portfolio
- 3-year compounded sales CAGR of 21% demonstrates consistent top-line expansion over a meaningful period
- TTM profit growth of 24% shows healthy earnings trajectory alongside revenue growth
- 3-year compounded profit CAGR of 20% reflects sustained earnings growth over multiple years
- Very low debt-to-equity ratio of 0.19 indicates a conservatively financed balance sheet with limited leverage risk
- Stock has delivered an impressive 1-year price CAGR of 85%, rising from a 52-week low of ₹800.45 to current levels of ₹1,696.5
- 3-year stock CAGR of 23% suggests the market has consistently rewarded the company's growth trajectory over a longer horizon
- The company is expected to deliver a good upcoming quarter, which could sustain the current earnings growth momentum
- P/B ratio of 8.68x (also flagged at 8.43x book value) indicates the stock is priced at a steep premium to its net asset base
- ROE of 8.94% (and a 3-year average of just 7.91%) is low for a company commanding such premium valuations, suggesting capital is not being deployed efficiently relative to the price paid
- Zero dividend yield despite reporting repeated profits means shareholders receive no cash returns, relying entirely on capital appreciation
- There are indications the company might be capitalizing interest costs, which could flatter reported profitability and understate true operating expenses
- 5-year average ROE of 10% and last year ROE of 10% have not shown meaningful improvement despite strong revenue growth, raising questions about long-term profitability scaling
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Aether Industries is executing well with 26% profit growth, a high-growth CEM/CRAMS mix nearing 66% of revenue, and a landmark exclusive DRA manufacturing deal with Baker Petrolite that opens a new addressable market. The stock's 85% YTD rally reflects strong fundamentals, though the elevated valuation leaves limited room for execution misses. No material headwinds emerged in recent news, and the forward outlook is strengthening with improved revenue visibility from the long-term DRA contract and continued business mix shift toward higher-value segments.
- Exclusive DRA manufacturing deal Nov 17
Aether signed a long-term exclusive agreement with Baker Petrolite to build India's first dedicated Drag Reducing Agents facility at Site Magnum, Panoli, Gujarat, providing strong revenue visibility and entry into the energy infrastructure market.
- Q2 FY27 profit up 26% YoY Oct 30
Net profit rose 26% YoY to ₹68 crore, revenue jumped 24% to ₹347.2 crore, and EBITDA grew 25.6% to ₹110.4 crore with a stable 31.8% margin in Q2 FY27.
- CEM business surges 50% YoY Oct 30
Contract Exclusive Manufacturing grew ~50% YoY and CRAMS expanded ~24% YoY, together accounting for ~66% of total revenue, on track toward the 70% target.
- Investor conference participation Nov 3
Aether Industries will attend investor conferences on Nov 16-17, with no unpublished price-sensitive information expected during meetings.
- Q2 FY27 earnings call uploaded Oct 30
Audio recording of the Q2 FY27 earnings conference call was uploaded to the company website per SEBI listing regulations.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 164 | 155 | 118 | 180 | 199 | 220 | 240 | 257 | 280 | 319 | 305 | 327 | 347 |
| Expenses | 118 | 124 | 107 | 137 | 145 | 155 | 161 | 175 | 192 | 207 | 222 | 224 | 237 |
| Operating Profit | 46 | 31 | 10 | 43 | 54 | 65 | 80 | 81 | 88 | 112 | 83 | 103 | 110 |
| OPM % | 28% | 20% | 9% | 24% | 27% | 29% | 33% | 32% | 31% | 35% | 27% | 31% | 32% |
| Other Income | 14 | 11.26 | 11.55 | 11.96 | 10.97 | 13.64 | 5.07 | −1 | 8.69 | −4 | 11.22 | 8 | 5.08 |
| Interest | 2 | 2 | 4 | 3 | 2 | 3 | 5 | 5 | 3 | 4 | 6 | 6 | 5.31 |
| Depreciation | 10 | 10 | 10 | 10 | 11 | 11 | 13 | 14 | 17 | 17 | 18 | 21 | 21.69 |
| Exceptional Items | — | −6.37 | −7.39 | −3 | −3.33 | −2.69 | −2.85 | — | −2.68 | — | −1.33 | — | — |
| PBT | 49 | 24 | 0 | 39 | 49 | 61 | 64 | 62 | 74 | 87 | 68 | 83 | 88.52 |
| Tax % | 25% | 27% | 486% | 24% | 28% | 29% | 21% | 24% | 27% | 26% | 21% | 25% | 23% |
| Net Profit | 37 | 17 | −1 | 30 | 35 | 43 | 50 | 47 | 54 | 64 | 54 | 63 | 68 |
| EPS (₹) | 2.77 | 1.31 | −0.11 | 2.26 | 2.63 | 3.27 | 3.79 | 3.55 | 4.07 | 4.86 | 4.07 | 4.73 | 5.12 |
| YoY Sales growth | 17 | −7 | −36 | 12 | 21 | 41 | 104 | 43 | 41 | 45 | 27 | 27 | 24 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 0 | 24 | 109 | 201 | 302 | 450 | 590 | 651 | 598 | 841 | 1,160 | 1,298 |
| Expenses | 3 | 1 | 22 | 85 | 154 | 230 | 338 | 422 | 465 | 466 | 598 | 796 | 890 |
| Operating Profit | −2 | −1 | 2 | 23 | 48 | 72 | 112 | 168 | 186 | 132 | 243 | 364 | 408 |
| OPM % | −252% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 10% | 21% | 24% | 24% | 25% | 28% | 29% | 22% | 29% | 31% | 31% |
| Other Income | 4 | 1 | 0 | 0 | 2 | 2 | 4 | 7 | 17 | 39.21 | 28 | 20.93 | 19 |
| Interest | 1 | 0 | 1 | 9 | 11 | 9 | 11 | 13 | 5 | 9 | 13 | 18 | 21 |
| Depreciation | 0 | 0 | 1 | 5 | 6 | 8 | 11 | 15 | 23 | 40 | 45 | 66 | 79 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | −13.76 | — | −8.98 | — |
| PBT | 0 | 0 | 1 | 9 | 33 | 57 | 94 | 146 | 174 | 110 | 213 | 291 | 327 |
| Tax % | 27% | 31% | 300% | 17% | 28% | 29% | 24% | 26% | 25% | 25% | 26% | 25% | — |
| Net Profit | 0 | 0 | −1 | 8 | 23 | 40 | 71 | 109 | 130 | 82 | 158 | 219 | 249 |
| EPS (₹) | 0.01 | 0.01 | −0.10 | 0.68 | 2.03 | 3.48 | 6.20 | 9.50 | 10.47 | 6.22 | 11.95 | 16.54 | 18.78 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Sales growth | — | −61 | 7,303 | 345 | 85 | 50 | 49 | — | 10 | −8 | 41 | 38 | 30 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 34 | 9 | 9 | 9 | 9 | 10 | 113 | 125 | 133 | 133 | 133 | 133 |
| Reserves | 0 | 0 | −1 | 7 | 30 | 70 | 164 | 274 | 1,120 | 1,931 | 2,093 | 2,323 | 2,461 |
| Borrowings | 35 | 53 | 111 | 126 | 126 | 172 | 211 | 291 | 16 | 183 | 200 | 458 | 675 |
| Other Liabilities | 1 | −21 | 19 | 18 | 42 | 50 | 67 | 92 | 120 | 154 | 218 | 288 | 333 |
| Total Liabilities | 45 | 65 | 137 | 159 | 207 | 300 | 453 | 770 | 1,380 | 2,401 | 2,644 | 3,201 | 3,602 |
| Fixed Assets | 1 | 1 | 56 | 100 | 106 | 129 | 216 | 257 | 646 | 853 | 1,117 | 1,496 | 1,510 |
| CWIP | 20 | 42 | 40 | 2 | 1 | 17 | 0 | 58 | 37 | 232 | 363 | 516 | 705 |
| Investments | 8 | 0 | 0 | 0 | 0 | 0 | 22 | 17 | 1 | 0 | 0 | 0 | 0 |
| Other Assets | 15 | 21 | 41 | 56 | 99 | 154 | 214 | 438 | 695 | 1,315 | 1,163 | 1,189 | 1,387 |
| Total Assets | 45 | 65 | 137 | 159 | 207 | 300 | 453 | 770 | 1,380 | 2,401 | 2,644 | 3,201 | 3,602 |
Cash Flow
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −3 | −6 | −9 | 6 | 23 | 18 | 23 | −5 | −7 | −16 | 100 | 142 |
| Investing | 2 | −14 | −48 | −11 | −13 | −48 | −77 | −151 | −348 | −424 | −418 | −619 |
| Financing | −6 | 17 | 57 | 4 | −10 | 33 | 55 | 169 | 439 | 894 | 1 | 244 |
| Net Cash Flow | −8 | −3 | −1 | 0 | 0 | 2 | 2 | 12 | 84 | 453 | −317 | −233 |
| Free Cash Flow | −16 | −29 | −63 | −5 | 10 | −30 | −53 | −157 | −363 | −444 | −352 | −481 |
| CFO/EBITDA | 157 | 994 | −400 | 26 | 60 | 43 | 39 | 17 | 14 | 1 | 64 | 54 |
Ratios
| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 4,358 | 167 | 88 | 87 | 76 | 88 | 101 | 145 | 142 | 125 | 123 |
| Inventory Days | 52 | 9,733 | 629 | 149 | 133 | 166 | 141 | 221 | 301 | 411 | 356 | 345 |
| Days Payable | 172 | 1,922 | 575 | 92 | 76 | 88 | 82 | 95 | 99 | 124 | 114 | 126 |
| Cash Conversion Cycle | −25 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 220 | 144 | 144 | 153 | 147 | 227 | 348 | 429 | 367 | 341 |
| Working Capital Days | −794 | 9,037 | −18 | 49 | 11 | 32 | 36 | 82 | 268 | 279 | 239 | 160 |
| ROCE % | −1% | 0% | 2% | 14% | 28% | 32% | 33% | — | 18% | 7% | 10% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aether Industries insights
61 extracted metrics across FY18–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q2 FY27 concall · Oct 2026PPT
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026PPT
- 15 Oct 2026
- 23 Sep 2026
- 26 May 2026
- 30 Sep 2025
- 10 Jan 2025
- General announcements 17 Nov 2026
- General announcements 3 Nov 2026
Frequently Asked Questions about Aether Industries
What does Aether Industries Ltd do?
Where is Aether Industries Ltd (AETHER) listed?
Which sector does Aether Industries Ltd belong to?
What is the market capitalisation of Aether Industries Ltd?
What is the PE ratio of Aether Industries Ltd?
What is the 52-week high and low of Aether Industries Ltd?
What is the Return on Equity (ROE) of Aether Industries Ltd?
Company Information
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AETHER.md for Aether Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.